SUBSCRIBE
SUBSCRIBE
News   Business

Ipsen’s First Half 2007 Results and Financial Objectives for the Full Year 2007

August 29, 2007 | 
1 min read
PARIS--(BUSINESS WIRE)--The Board of Directors of Ipsen (Paris:IPN), chaired by Jean-Luc Bélingard, met on 28 August 2007 to review the Group’s results for the first half of 2007, published today.
Earnings Europe
Ipsen Biopharmaceuticals, Inc.
MORE ON THIS TOPIC
A bottle of a vaccine on a reflective surface with the illuminated red outline of the world map in red - 3D render
Vaccines
Moderna’s mRNA Tech Could Boost Flu Shot Efficacy. Americans Will Have To Wait
February 16, 2026
 · 
3 min read
 · 
Annalee Armstrong
Businessman on a crossroad. Man choosing career. Searching of right path. Decision and brainstorming concept. Flat vector illustration.
Earnings
Moderna’s FDA Challenges Stymie Breakeven Goal in ‘Fresh and Fluid’ Situation
February 13, 2026
 · 
5 min read
 · 
Annalee Armstrong
Adult people customers group in casual clothes standing in long line queue
Gene therapy
Vertex, CRISPR Set Lofty Goal for Casgevy Gene Therapy as Patient Starts Ramp
February 13, 2026
 · 
3 min read
 · 
Dan Samorodnitsky
Various white pills and capsules forming a map of the world, illustrating humanity's increasing dependency on medication manufacturing.
Obesity
Lilly Prepares $1B+ Orforglipron Stock Ahead of Approval as Novo Brings Wegovy Pill Overseas
February 13, 2026
 · 
2 min read
 · 
Tristan Manalac